FDA orders blindness warning on Ozempic and Wegovy

The US Food and Drug Administration has said makers of popular weight loss drugs, including Ozempic and Wegovy, must add a warning label about a rare eye condition that can cause blindness. The move puts fresh attention on safety risks tied to some of the most widely watched obesity medicines.




